Civil Litigation,
Intellectual Property
Mar. 30, 2018
US appeals court stays review of Allergan eye drug patents
A federal appellate court has ordered the Patent Trial and Appeal Board to halt its review of Allergan PLC patents that were transferred to a Native American tribe while the court considers the issue of tribal immunity.
A federal appellate court ordered the Patent Trial and Appeal Board to halt its review of Allergan PLC patents that were transferred to a Native American tribe while the court considers the issue of tribal immunity.
The case began in September, when Allergan transferred six patents for its dry eye drug, Restasis, to the Saint Regis Mohawk Tribe in New York to take advantage of the tribe's sovereign immunity and circumvent review in...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In